Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, Korn JH, Simms RW, Csuka ME, Medsger TA Jr, Rothfield NF, Ellman MH, Collier DH, Weinstein A, Furst DE, Jiménez SA, White B, Seibold JR, Wigley FM; Scleroderma Clinical Trials Consortium.
Merkel PA, et al. Among authors: wigley fm.
Arthritis Rheum. 2002 Sep;46(9):2410-20. doi: 10.1002/art.10486.
Arthritis Rheum. 2002.
PMID: 12355489
Free article.